financetom
Business
financetom
/
Business
/
Expedia Group Insider Sold Shares Worth $1,028,500, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Expedia Group Insider Sold Shares Worth $1,028,500, According to a Recent SEC Filing
Feb 19, 2025 2:31 PM

05:12 PM EST, 02/19/2025 (MT Newswires) -- Robert J Dzielak, Chief Legal Officer & Secretary, on February 15, 2025, sold 5,000 shares in Expedia Group ( EXPE ) for $1,028,500. Following the Form 4 filing with the SEC, Dzielak has control over a total of 74,502 commo shares of the company, with 74,502 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1324424/000122520825001978/xslF345X05/doc4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
HF Sinclair reports Q3 loss amid refining margin slump
HF Sinclair reports Q3 loss amid refining margin slump
Nov 3, 2024
Oct 31 (Reuters) - Refiner HF Sinclair reported a loss in the third quarter compared to a year-ago profit on Thursday, hurt by a slump in margins, especially in the West and Mid-Continent regions, due to an oversupply of fuel. The Dallas-based refiner posted a loss of $75.9 million, or 40 cents per share, for the quarter ended September 30,...
Regeneron Pharmaceuticals' Q3 Adjusted Net Income, Revenue Rises
Regeneron Pharmaceuticals' Q3 Adjusted Net Income, Revenue Rises
Nov 3, 2024
07:13 AM EDT, 10/31/2024 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) reported Q3 non-GAAP net income Thursday of $12.46 per diluted share, up from $11.59 a year earlier. Analysts polled by Capital IQ expected $11.71. Total revenue for the quarter ended Sept. 30 was $3.72 billion, up from $3.36 billion a year earlier. Analysts surveyed by Capital IQ expected...
Entergy's Q3 Adjusted Earnings Decline; Raises Lower End of Fiscal 2024 Adjusted EPS Guidance
Entergy's Q3 Adjusted Earnings Decline; Raises Lower End of Fiscal 2024 Adjusted EPS Guidance
Nov 3, 2024
07:11 AM EDT, 10/31/2024 (MT Newswires) -- Entergy ( ETR ) reported Q3 adjusted earnings Thursday of $2.99 per share, down from $3.27 a year earlier. Analysts polled by Capital IQ expected $2.99. The company said it now expects fiscal 2024 adjusted EPS of $7.15 to $7.35. That compares with its previous forecast of $7.05 to $7.35. Analysts polled by...
BRIEF-Aerovate Therapeutics And Jade Biosciences Announce Merger Agreement
BRIEF-Aerovate Therapeutics And Jade Biosciences Announce Merger Agreement
Nov 3, 2024
Oct 31 (Reuters) - Aerovate Therapeutics Inc ( AVTE ): * AEROVATE THERAPEUTICS AND JADE BIOSCIENCES ANNOUNCE MERGER AGREEMENT * AEROVATE THERAPEUTICS INC ( AVTE ) - JADE SECURES $300 MILLION IN PRIVATE INVESTMENT * AEROVATE THERAPEUTICS INC ( AVTE ) - STOCKHOLDERS TO OWN 1.6% OF COMBINED COMPANY * AEROVATE THERAPEUTICS INC ( AVTE ) - TOM FROHLICH TO...
Copyright 2023-2026 - www.financetom.com All Rights Reserved